The frequencies of CD19+CD20+CD138+ PBs and IgM+IgD+-expressing CD19+CD20+CD138+ PBs were significantly decreased in the blood of patients with MASLD (Fig. S8G). This evidence concerns the gene SDC1 and metabolic dysfunction-associated steatotic liver disease.